Hospital
Peking University Cancer Hospital北京大学肿瘤医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A+ General list, 2023
-
National key clinical specialties 2 at evidence level A or B
-
Published research 15 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 95 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A+ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
Fudan specialty reputation ranking
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| Medical Oncology 肿瘤学 | #4 | 2023 | Place in the specialty reputation ranking | https://www.fdygs.com/news2023-1.aspx |
National key clinical specialties
| Specialty | Evidence | Source |
|---|---|---|
| Pathology 病理科 | Level B | https://www.bjcancer.org/Html/Hospitals/Main/Description.html |
| Medical Oncology 肿瘤科 | Level B | https://www.bjcancer.org/Html/Hospitals/Main/Description.html |
Batch is not published by the source.
2 specialty rows, each carrying its own evidence level.
Each row carries its own evidence level and its own source. Level definitions are on the methodology page.
Values written in Chinese are quoted as published by the source.
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 北京大学肿瘤医院
- English name
- Peking University Cancer Hospital
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Also known as
- Beijing Cancer Hospital
- Beijing Institute for Cancer Research
- Peking University School of Oncology
- Peking University Cancer Hospital & Institute
- PKUCH
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- LncRNA CCAT1/miR-490-3p/VDAC1 Axis Promotes Colorectal Cancer Progression by Activating Glycolysis. Biochemical genetics, 2026
- IER5L promotes p53 degradation via TRAF7-mediated ubiquitination to facilitate EMT and colorectal cancer malignancy. Cellular signalling, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology #4, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Breast cancer
Published research
- Glucose stabilizes the KLF5 transcription factor to promote glycolysis and malignancy of basal-like breast cancer. Science bulletin, 2026
- [Study on the relationship between ultrasound-based response evaluation and pathological outcomes in neoadjuvant therapy for HER2-positive breast cancer]. Zhonghua yi xue za zhi, 2026
4 more published studies
PubMed indexes 6 papers on this condition that name this hospital.
Also ranked: Medical Oncology #4, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Lung cancer
Published research
- Frailty profiles and symptomatic radiation pneumonitis in patients with lung cancer undergoing radiotherapy: A latent class analysis. Asia-Pacific journal of oncology nursing, 2026
- Huangqi Guizhi Wuwu Decoction Ameliorates Cachexia in Lung Cancer Mice Through Regulating Amino Acid Metabolism: Insights From Transcriptomics, Metabolomics and Experimental Validation. Journal of cellular and molecular medicine, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology #4, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Liver cancer
Published research
- Eliminating cancer stem cells can inhibit progression of residual hepatocellular carcinoma after radiofrequency ablation. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Medical Oncology #4, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Stomach cancer
Published research
- SENP1 drives glycolytic reprogramming to promote malignant progression of gastric cancer via deSUMOylation of HIF-1α. Tissue & cell, 2026
- Morphological CT signs of Epstein-Barr virus-associated locally advanced gastric cancer: a radiological-pathological comparison study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology #4, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Nasopharyngeal carcinoma
Published research
- Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Medical Oncology #4, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Esophageal cancer
Published research
- Intratumoral and peritumoral radiomics for preoperative prediction of pathological complete response to neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma. European journal of radiology open, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Medical Oncology #4, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Pancreatic cancer
Fudan specialty reputation ranking 2023
- Medical Oncology #4 https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Medical Oncology (level B) https://www.bjcancer.org/Html/Hospitals/Main/Description.html
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
-
Bone and soft tissue sarcoma
Fudan specialty reputation ranking 2023
- Medical Oncology #4 https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Medical Oncology (level B) https://www.bjcancer.org/Html/Hospitals/Main/Description.html
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
Other hospitals in Beijing
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24